GlassScriptPhysician profile
Alyssa Pham
NPI 1316435845
$12,720.24
in general payments reported to CMS, 2019-2025
23 companies · $192 in 2025
The $192 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.83 · 2021: $1,429 · 2022: $8,205 · 2023: $2,453 · 2024: $425 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,539 · Food and Beverage: $1,531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,539.30 |
| Food and Beverage | $1,530.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $8,186.48 | 2021-2023 | |
| Acumed LLC | $1,821.66 | 2022-2023 | Acumed, Osteomed |
| Medline Industries LP | $991.45 | 2022 | |
| Mvp Orthopedics INC | $467.28 | 2022-2023 | |
| Biotissue Holdings INC. | $203.44 | 2021 | |
| Integra Lifesciences Corporation | $143.04 | 2022 | |
| Abbvie INC. | $140.25 | 2022-2023 | |
| Treace Medical Concepts, INC. | $126.19 | 2024-2025 | |
| Organogenesis INC. | $119.17 | 2024 | Nushield |
| Medtronic, INC. | $96.63 | 2022 | |
| Alafair Biosciences, INC. | $66.15 | 2024 | Versawrap |
| Stryker Corporation | $64.22 | 2024 | Citrefix, 7 X 23mm Citrelock Implant |
| Amgen INC. | $55.84 | 2024-2025 | Krystexxa |
| Smith+Nephew, INC. | $49.99 | 2025 | Renasys Touch |
| Bioventus LLC | $35.04 | 2024-2025 | Exogen Ultrasound Bone Healing System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $25.58 | 2025 | Purified Cortrophin Gel |
| Kci USA, INC. | $24.38 | 2022 | |
| Abbott Laboratories | $21.26 | 2024 | Proclaim |
| Fidia Pharma USA INC. | $19.16 | 2025 | |
| Paratek Pharmaceuticals, INC. | $17.63 | 2025 | Nuzyra |
| Averitas Pharma INC. | $16.70 | 2024 | Qutenza |
| Linvatec Corporation | $15.83 | 2019 | |
| Medinc of Texas | $12.87 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.